Earnings call: X4 Pharmaceuticals reports Q1 2024 results and drug developments By Investing.com

Published on 7 May 2024 on Investing.com

X4 Pharmaceuticals (NASDAQ:XFOR) has announced its financial results for the first quarter of 2024...

Read the rest of the article

Start tracking your investments with Statfolio

As the U.S. stock market experiences a positive shift following recent executive orders, investor...

Simply Wall St. · via Yahoo Finance 21 Jan 2025

As the U.S. stock market experiences fluctuations ahead of major earnings reports, investors are...

Simply Wall St. · via Yahoo Finance 20 Nov 2024

Cash and Equivalents: Ended the third quarter of 2024 with almost $136 million. Sales Strategy:...

GuruFocus.com · via Yahoo Finance 14 Nov 2024

X4 Pharmaceuticals (NASDAQ:XFOR) has announced its financial results for the first quarter of 202...

Investing.com 7 May 2024

X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Q1 2024 Earnings Call Transcript May 7, 2024 X4 Pharmaceut...

Insider Monkey via Yahoo Finance 6 May 2024

Key Insights Institutions' substantial holdings in X4 Pharmaceuticals implies that they have sign...

Simply Wall St. via Yahoo Finance 11 Apr 2024

X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Q4 2023 Earnings Call Transcript March 21, 2024 X4 Pharmac...

Insider Monkey via Yahoo Finance 22 Mar 2024

X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Q3 2023 Earnings Call Transcript November 9, 2023 X4 Pharm...

Insider Monkey via Yahoo Finance 10 Nov 2023

<img src=https://s.yimg.com/ny/api/res/1.2/8F0WmOInKal6eTxqYqBbWw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyM...

GuruFocus.com via Yahoo Finance 9 Nov 2023

Washington Post 9 Nov 2023